Clinical Trial Management System (CTMS) Software

Summary

The problem: A milestone or site-activation date can look on track while the evidence behind it, such as training records or receipt acknowledgements, is still missing in another system.
Seal’s approach: Each milestone links to the evidence behind it across CTMS, eTMF, training and trial-supply records. Neil can assess site readiness against the selected plan and prepare monitoring and follow-up work.
What changes: Activation stays a decision recorded by the authorised study team, sponsor oversight shows delegated CRO work alongside its evidence, and remaining obligations stay visible through closeout.
Where to start: One site followed from activation through a monitoring finding to closeout, including late evidence, a conditional decision and a changed protocol version. Book a demo.

Put one question to the records.

We plan to activate three sites on Friday. Which are actually ready, and what needs chasing?

Neil

Site 101 has evidence for all four checks in the activation plan. Site 205 is missing amendment-training evidence. Site 309 has a dispatch record, but no pharmacy receipt acknowledgement. I would not treat those as three ready sites.

Evidence behind Friday’s plan

DocumentsTrainingInitiationReceipt

Site 101Ready for activation review

Site 205Training evidence missing

Site 309Receipt acknowledgement missing

Checks from this site plan. The activation decision is still separate.

One site can go to activation review. Two need specific evidence before the same review can proceed.

About this example

A prepared conversation using fictional records, not a live query. Source buttons open the example evidence. The draft can be read and downloaded; no records are changed, shared or approved.

Connect the plan to what has happened.

A milestone date tells you the intention. The document, visit, receipt or decision tells you whether the work supports it. Seal connects those records at study, country and site level.

Keep your CTMS and eTMF where they are, or configure the operational workflow in Seal. Scoped connections can bring in enrolment, essential-document status and partner deliverables. Retain the source update time so yesterday’s export cannot quietly become today’s assertion of readiness.

Why teams choose Seal for trial management.

A CTMS tracks milestones and visit dates, while the documents, training records, supply receipts and decisions that show whether a site is ready live in the eTMF, the LMS and the supply system. Seal connects the plan to those records at study, country and site level, so readiness is read from evidence rather than from a status colour.

Neil can prepare the activation or visit follow-up from the connected records, and the study lead makes the recorded decision.

Give the monitor a useful next step.

Ask Neil to prepare the visit brief, compare it with previous findings and draft the follow-up. The useful output is a specific action and the evidence it needs, rather than another status colour on a dashboard.

Connect monitoring findings, site responses and sponsor review. Link payment milestones to the agreed contract and accepted evidence, rather than assuming a visit in EDC is automatically payable. Keep CRO deliverables and sponsor decisions together without blurring their responsibilities.

Finish the obligations, not just the visit.

Use the same connected work at closeout: unresolved findings, missing essential documents, supply accountability and outstanding payments remain inspectable after the last visit.

For a first implementation, follow one site from activation through a monitoring finding to closeout. Test late evidence, conditional decisions and a changed protocol version. The workflow should preserve what was known when each decision was made, and who still has work to do.

What the blueprint configures.

Explore the configured capabilities

Study planning

Version the protocol-driven plan, country dependencies, site milestones and responsibilities. Keep targets separate from recorded decisions.

Site management

Connect feasibility, qualification, activation requirements and closeout obligations to their evidence.

Enrolment tracking

Compare sourced enrolment counts with the agreed plan. Preserve the cutoff and denominator before interpreting changes.

Monitoring visits

Prepare the visit from prior findings and current evidence. Link observations, site responses and reviewer decisions.

Trial master file

Connect expected documents to the site and event that require them. Filing, completeness and approval remain separate checks.

Explore this blueprint

Clinical quality

Carry a site issue into assessment and owned follow-up without losing its original observation or protocol context.

Explore this blueprint

Payment milestones

Compare claimed milestones with the contract version and accepted supporting records before payment review.

Explore the connected records

Continue into the connected work.

AQuestions and answers

Can Seal work with our existing CTMS and eTMF?

Yes, through agreed connections or selected exports. Scope the source records, identifiers, permissions and update frequency. You can begin with one cross-system review without moving the whole trial.

What does CTMS own versus EDC and eTMF?

CTMS manages operational plans, sites, visits, milestones and follow-up. EDC holds case-report data and cleaning activity; eTMF holds essential documents. Link the relevant records while preserving each source’s role and version.

Can Neil activate a site?

Neil can assess the available evidence against the selected plan and prepare follow-up work. The authorised study team records the activation decision. A target date, a completed checklist or this example conversation does not activate a site.

How does this support sponsor oversight?

Connect delegated scope, expected CRO deliverables, findings, sponsor reviews and outstanding actions. Keep the responsible sponsor role and the evidence for each decision visible alongside the partner’s work.

Can monitoring be risk based?

Configure the monitoring plan around the study’s critical data and processes. Use permitted site signals and prior findings to inform a reviewed visit plan. A query count or age alone is not a clinical risk score.

How do payments and closeout work?

Link payment milestones to the applicable agreement and accepted evidence. Keep unresolved findings, supply accountability, documents and remaining obligations visible through closeout instead of treating the last visit as proof that everything is finished.

Move the trial forward. Know what is still missing.